- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.78 Å
- Oligo State
- monomer
- Ligands
- 1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
- 1 x ORO: OROTIC ACID(Non-covalent)
ORO.2: 10 residues within 4Å:- Chain A: K.73, N.118, R.119, Y.120, G.121, F.122, N.185, N.257, T.258
- Ligands: FMN.1
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.122
- Hydrogen bonds: A:N.118, A:N.118, A:N.118, A:G.121, A:F.122, A:N.185, A:N.257, A:N.257
- Salt bridges: A:K.73
- 1 x T6L: (6M)-N-(2-chloro-6-fluorophenyl)-6-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}pyridine-3-carboxamide(Non-covalent)
T6L.3: 22 residues within 4Å:- Chain A: Y.11, M.16, L.19, Q.20, L.23, P.25, A.28, H.29, L.31, A.32, F.35, T.36, L.40, L.41, F.71, R.109, V.116, Y.329, L.332, T.333, P.337
- Ligands: FMN.1
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:Y.11, A:L.19, A:A.28, A:A.32, A:F.35, A:L.41, A:T.333, A:P.337
- Hydrogen bonds: A:Q.20
- Water bridges: A:T.333
- Halogen bonds: A:A.32, A:T.36
- 4 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 2 residues within 4Å:- Chain A: K.280, P.281
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:K.280
ACT.13: 6 residues within 4Å:- Chain A: Q.141, A.142, T.145, A.179, D.180
- Ligands: SO4.14
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.145
- Water bridges: A:A.142
ACT.15: 3 residues within 4Å:- Chain A: H.125, V.129, R.133
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:H.125, A:R.133
ACT.16: 4 residues within 4Å:- Chain A: Q.99, N.158, K.159, T.160
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:Q.99
- Hydrogen bonds: A:Q.99, A:N.158, A:K.159, A:T.160
- 8 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 7 residues within 4Å:- Chain A: E.26, H.29, R.30, K.73, H.74, Y.120, N.123
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:E.26, A:R.30, A:N.123
- Water bridges: A:H.29, A:H.74
GOL.6: 6 residues within 4Å:- Chain A: R.55, V.56, S.324, T.360, I.363
- Ligands: GOL.7
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.324
GOL.7: 6 residues within 4Å:- Chain A: Y.294, G.299, T.360, I.363, R.368
- Ligands: GOL.6
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.294, A:G.299, A:R.368, A:R.368
GOL.9: 3 residues within 4Å:- Chain A: Q.212, D.215, G.216
No protein-ligand interaction detected (PLIP)GOL.12: 5 residues within 4Å:- Chain A: G.58, H.59, K.60, T.145, E.146
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:G.58, A:K.60, A:K.60, A:E.146
GOL.18: 6 residues within 4Å:- Chain A: P.96, K.97, L.127, S.128, E.170, V.174
2 PLIP interactions:2 interactions with chain A- Water bridges: A:S.128, A:E.170
GOL.19: 4 residues within 4Å:- Chain A: K.200, E.239, D.240, S.243
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.200, A:E.239
GOL.20: 4 residues within 4Å:- Chain A: R.262, P.263, R.271, S.272
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:P.263, A:S.272
- Water bridges: A:G.265
- 5 x SO4: SULFATE ION(Non-functional Binders)
SO4.8: 4 residues within 4Å:- Chain A: R.214, D.215, R.222
- Ligands: SO4.17
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:R.214, A:R.222
SO4.10: 3 residues within 4Å:- Chain A: R.218, R.219, R.222
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:R.219
- Water bridges: A:R.218, A:R.218, A:V.220, A:R.222, A:R.222
- Salt bridges: A:R.218
SO4.11: 2 residues within 4Å:- Chain A: R.218, H.221
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:R.218, A:H.221
SO4.14: 8 residues within 4Å:- Chain A: H.59, A.179, D.180, V.220, H.221, R.222, P.223
- Ligands: ACT.13
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.222
- Salt bridges: A:H.59
SO4.17: 6 residues within 4Å:- Chain A: L.211, R.214, D.215, L.248, G.249
- Ligands: SO4.8
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.215
- Water bridges: A:R.214
- Salt bridges: A:R.214
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cisar, J.S. et al., N -Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia. J.Med.Chem. (2022)
- Release Date
- 2022-08-17
- Peptides
- Dihydroorotate dehydrogenase (quinone), mitochondrial: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.78 Å
- Oligo State
- monomer
- Ligands
- 1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
- 1 x ORO: OROTIC ACID(Non-covalent)
- 1 x T6L: (6M)-N-(2-chloro-6-fluorophenyl)-6-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}pyridine-3-carboxamide(Non-covalent)
- 4 x ACT: ACETATE ION(Non-functional Binders)
- 8 x GOL: GLYCEROL(Non-functional Binders)
- 5 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cisar, J.S. et al., N -Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia. J.Med.Chem. (2022)
- Release Date
- 2022-08-17
- Peptides
- Dihydroorotate dehydrogenase (quinone), mitochondrial: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A